Pieris Pharmaceuticals Appoints Industry Expert to Board of Directors

The Board of Directors is one of the most important elements of a publicly-traded company, as the board makes key decisions regarding major company issues or corporate actions. That said, when...

NewLink Genetics Shares Plummet to Over Five-Year Lows Today, and Here’s What You Need...

NewLink Genetics Corp (NASDAQ:NLNK) shares closed down over 40% today, and NLNK hit levels it hasn’t seen in over five years, following the company’s business update conference call during the pre-market....
Synergy

Here’s Why Synergy Pharma Shares Soar 10% Today

Synergy Pharmaceuticals (NASDAQ: SGYP) shares ended the day up over 10% after Cantor Fitzgerald initiated coverage on SGYP yesterday. Check out the daily chart on SGYP. Source: TradingView Let's take a look at...

What You Need to Know About Clinical Trials for Biotech Stocks

Let’s face it...biotech stocks are difficult to understand when you’re first starting out. Biotech stocks are volatile, and your account could suffer, if you don’t know what you’re looking for or...

Catabasis Pharmaceuticals Inc (NASDAQ: CATB) Up Over 80% last week, Here’s Why…

Catabasis Pharmaceuticals Inc (NASDAQ: CATB) shares were up significantly, on March 10, 2017, CATB was up 53.38% at the close. Markets participants exchanged 59,565,706 shares, over 20.36 times the 30-day average...

Here’s Why TG Therapeutics (TGTX) Was On Fire Yesterday

TG Therapeutics (NASDAQ: TGTX) shares were on fire, and the stock returned 90.65% on March 6, 2017. After Monday, TGTX was up 119.35% YTD and 82.14% over the past three months. Additionally,...
XBIT

Geron (NASDAQ: GERN) Options Activity Indicating A Potential Drop

Geron Corporation (NASDAQ: GERN) sold off nearly 3% today, on above normal trading volume. However, that’s not what caught our attention today. We were focused on the options market, as we...

Vanda Pharmaceuticals Ended Up Over 8%, and Here’s What You Need Know

Vanda Pharmaceuticals Inc (NASDAQ: VNDA) shares were up over 8% today, after an investment company filed an SEC Schedule 13G. Additionally, there were other insiders who filed SEC Form 4s. That...

Celldex Therapeutics (NASDAQ: CLDX) Ready To Make A Move Above $4

Option players were out in full force today in Celldex Therapeutics, Inc. (NASDAQ: CLDX), biotech company developing therapeutics to address devastating diseases. With that said, we saw 5.2 times normal options...
Pharmaceuticals

Sangamo Therapeutics Soars After Q1 2017 Results and Strategic Collaboration

It’s earnings season, and traders are focused closely on what companies say in their press release. Now, this gives companies a chance to show investors how they performed in the reported...